Recia Mickens-lopez, APRN-CNP Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 717 S 30th St, Heath, OH 43056 Phone: 248-470-3247 |
Eta Bea Musonge, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 717 S 30th St, Heath, OH 43056 Phone: 740-522-1171 |
Mrs. Kristina Elizabeth Skinner, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 607 Hebron Rd, Heath, OH 43056 Phone: 937-450-1244 |
Holly Ann Randall, Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 623 Louise Ave, Heath, OH 43056 Phone: 740-404-6522 |
Deborah Turley, CNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 650 Partridge Rd, Heath, OH 43056 Phone: 740-405-1739 |
Dr. Jo Ann Dowell, PHD, CRNP,PNP,FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 607 Hebron Rd, Heath, OH 43056 Phone: 614-493-6110 |
Mrs. Melinda S Mcgaughy, CRNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 764 Hebron Rd, Heath, OH 43056 Phone: 740-522-2242 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved Merck & Co.'s Juvisync diabetes drug, a combination pill for type 2 diabetes. Juvisync combines two Merck drugs already on the market, 1) glucose-lowering Januvia (Sitagliptin) medication and 2) cholesterol-lowering Zocor (Simvastatin).
Even in challenging cases, CT angiography (CTA) offers an accurate and rapid diagnosis for blunt trauma victims who may have aortic or great vessel injury negating the need for more invasive procedures, according to a recent study conducted by radiologists at the University of Washington and the Harborview Injury Prevention and Research Center in Seattle, WA.
The addition of a GP clinic at hospitals should reduce waiting times in emergency departments, according to new research.
Elderly people with the metabolic syndrome-defined as having multiple risk factors associated with developing diabetes and heart disease-had an increased risk of chronic kidney disease, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Unilife Corporation today announced it has commenced initial production of the Unifill ready-to-fill syringe at its FDA-registered manufacturing facility in York, Pennsylvania.
› Verified 4 days ago